• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) UNIFY ASSURA CRT-D RF HV; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) UNIFY ASSURA CRT-D RF HV; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD3357-40C
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Under-Sensing (1661)
Patient Problems Syncope (1610); Fall (1848); Hip Fracture (2349)
Event Date 09/02/2020
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported that the patient experienced syncope, fell, and broke his hip and presented to the emergency room.Upon examination, it was found that the implantable cardioverter defibrillator had noise oversensing on all three lead channels that resulted in pacing inhibition.It was suspected that the oversensing may have been caused by electromagnetic interference (emi).The patient was asked if he was exposed to any possible electromagnetic interference at home.However, he could not recall being near any possible source of electrical equipment or power source.The device therapy was then turned off and was programmed to pace in the ventricle only in preparation for his hip repair surgery.Subsequently, the patient had a successful hip repair surgery and the device therapy was turned on again.It was also noted that the right ventricular lead impedance had slowly been rising over the years.No other intervention was performed at this time.It was reported that the patient remained in stable condition while recovering at the hospital.Related manufacturer reference number: 2017865-2020-14037, 2017865-2020-14038, 2017865-2020-14039.
 
Manufacturer Narrative
The implantable cardioverter defibrillator system did not exhibit episodes of undersensing.The previous report should have stated that there were noise oversensing episodes prior to the patient's fall.
 
Manufacturer Narrative
Additional information: b5 and h6 device code.
 
Event Description
New information received stated that prior to the patient's fall, the device and leads also exhibited undersensing.It was then noted that right ventricular lead impedance continued to increase slowly.On oct.20th, 2020, the right ventricular lead was capped and replaced without any complications.The patient's condition remained stable after the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNIFY ASSURA CRT-D RF HV
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
MDR Report Key10570639
MDR Text Key208085389
Report Number2017865-2020-14036
Device Sequence Number1
Product Code NIK
UDI-Device Identifier05414734508186
UDI-Public05414734508186
Combination Product (y/n)N
PMA/PMN Number
P030054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup,Followup
Report Date 11/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model NumberCD3357-40C
Device Catalogue NumberCD3357-40C
Device Lot NumberA000060288
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/02/2020
Initial Date FDA Received09/22/2020
Supplement Dates Manufacturer Received10/16/2020
11/06/2020
Supplement Dates FDA Received11/05/2020
11/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
QUICKSITE; RIATA; TENDRIL SDX
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age82 YR
Patient Weight66
-
-